ZA98484B - Use of beta3-adrenergic receptor agonists for the preparation of healing drugs - Google Patents

Use of beta3-adrenergic receptor agonists for the preparation of healing drugs

Info

Publication number
ZA98484B
ZA98484B ZA98484A ZA98484A ZA98484B ZA 98484 B ZA98484 B ZA 98484B ZA 98484 A ZA98484 A ZA 98484A ZA 98484 A ZA98484 A ZA 98484A ZA 98484 B ZA98484 B ZA 98484B
Authority
ZA
South Africa
Prior art keywords
beta3
preparation
receptor agonists
adrenergic receptor
healing drugs
Prior art date
Application number
ZA98484A
Other languages
English (en)
Inventor
Andre Bernat
Jean-Marc Herbert
Michele Arnone
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA98484B publication Critical patent/ZA98484B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA98484A 1997-01-21 1998-01-21 Use of beta3-adrenergic receptor agonists for the preparation of healing drugs ZA98484B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9700584A FR2758460B1 (fr) 1997-01-21 1997-01-21 Utilisation des agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants

Publications (1)

Publication Number Publication Date
ZA98484B true ZA98484B (en) 1998-07-30

Family

ID=9502810

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA98484A ZA98484B (en) 1997-01-21 1998-01-21 Use of beta3-adrenergic receptor agonists for the preparation of healing drugs

Country Status (15)

Country Link
US (1) US6235793B1 (pt)
EP (1) EP0966276B1 (pt)
JP (1) JP2001508790A (pt)
AR (1) AR011546A1 (pt)
AT (1) ATE255889T1 (pt)
AU (1) AU5994198A (pt)
BR (1) BR9807288A (pt)
CA (1) CA2278220A1 (pt)
DE (1) DE69820422T2 (pt)
FR (1) FR2758460B1 (pt)
HR (1) HRP980023A2 (pt)
NO (1) NO326823B1 (pt)
UY (1) UY24848A1 (pt)
WO (1) WO1998031357A1 (pt)
ZA (1) ZA98484B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2817257B1 (fr) 2000-11-30 2009-03-20 Sanofi Synthelabo Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
JPWO2003106423A1 (ja) * 2002-06-12 2005-10-13 住友製薬株式会社 環状アミン類およびそれを含む医薬組成物
BRPI0720487B8 (pt) 2006-12-22 2020-12-01 Nat Oilwell Varco Denmark Is tubo flexível
EP2100066B1 (en) * 2006-12-22 2013-01-23 National Oilwell Varco Denmark I/S A flexible pipe
AU2022221588A1 (en) * 2021-02-22 2023-09-07 Northern Sydney Local Health District Wound healing methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070865D1 (en) * 1979-11-15 1985-08-14 Beecham Group Plc Secondary ethanol amines, their preparation and their use in pharmaceutical compositions
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5502078A (en) * 1991-05-28 1996-03-26 Zeneca Limited Chemical compounds
GB9308178D0 (en) * 1993-04-21 1993-06-02 Smithkline Beecham Plc Novel compounds
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
JPH07228543A (ja) * 1994-02-16 1995-08-29 Fujisawa Pharmaceut Co Ltd β３−アドレナリン作動薬の新規医薬用途
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US5512592A (en) * 1994-09-09 1996-04-30 Wake Forest University Method of producing cardiotonic effect and improving cardiac contractile function by administration of carnosine
US5597843A (en) 1995-06-07 1997-01-28 Houghten Pharmaceuticals Use of a substituted 1,3-benzodioxole to reduce a wasting condition
US5869450A (en) * 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs

Also Published As

Publication number Publication date
EP0966276B1 (fr) 2003-12-10
NO326823B1 (no) 2009-02-23
US6235793B1 (en) 2001-05-22
NO993548L (no) 1999-07-20
EP0966276A1 (fr) 1999-12-29
FR2758460B1 (fr) 1999-12-31
AU5994198A (en) 1998-08-07
ATE255889T1 (de) 2003-12-15
HRP980023A2 (en) 1998-10-31
DE69820422T2 (de) 2004-10-28
WO1998031357A1 (fr) 1998-07-23
JP2001508790A (ja) 2001-07-03
UY24848A1 (es) 1998-04-21
NO993548D0 (no) 1999-07-20
AR011546A1 (es) 2000-08-30
BR9807288A (pt) 2000-03-21
DE69820422D1 (de) 2004-01-22
CA2278220A1 (en) 1998-07-23
FR2758460A1 (fr) 1998-07-24

Similar Documents

Publication Publication Date Title
ZA98691B (en) Use of central cannabinoid receptor antagonists for the preparation of drugs
GB2301537B (en) Two-component device for the administration of drugs
HUP0203638A3 (en) Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them and their use
HUP0203681A3 (en) Pharmaceutical compositions containing agonists specific for the peripheral cannabinoid receptor and their use
HK1030543A1 (en) Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
EG24044A (en) pharmaceutical formulation of omeprazole
HUP0201545A3 (en) Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them
HUP0100266A3 (en) 1-amino-alkylcyclohexane nmda receptor antagonists, pharmaceutical compositions containing the compounds and their preparations
IL133420A0 (en) Pharmaceutical composition for combination of piperidinoalkanol-decongestant
PL348112A1 (en) Pharmaceutical moxifloxacin preparation
SI0918059T1 (en) Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
EP1036573A4 (en) DEVICE FOR ADMINISTERING A SUBSTANCE THROUGH THE SKIN OR A MUCUTINE
ZA971869B (en) Implants with phasewise release of pharmaceutical substance.
HUP9900886A3 (en) Use of bisphosphonates preventing bone loss associated with immunosuppressive therapy for the preparation of pharmaceutical compositions
HUP0002303A3 (en) Benzofurazan derivatives and their use for the preparation of pharmaceutical compositions which enhance ampa receptor activity
HUP0100171A3 (en) Use of endothelin receptor antagonists for producing pharmaceutical preparations for combating obesity
AU7788500A (en) Use of substance p antagonists for influencing the circadian timing system
IL127947A0 (en) Pharmaceutical use of adenosine agonists
ZA98484B (en) Use of beta3-adrenergic receptor agonists for the preparation of healing drugs
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
ZA956546B (en) Use of neurotensin antagonists for the preparation of diuretic drugs
EP1019504A4 (en) ISO FORM OF THE HUMAN VITAMIN D RECEPTOR
IL149266A0 (en) Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension
ZA981206B (en) Use of NMDA receptor antagonist
HUP9903183A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions with analgetic activity